Canadian (TSX) Healthtech Industry Analysis

Industry Valuation and Performance

Has the Canadian Healthtech Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE
Sat, 28 May 2022	CA$717.8m	CA$135.8m	-CA$143,356,849.00	733.9x
Mon, 25 Apr 2022	CA$890.7m	CA$110.6m	-CA$180,344,600.00	483.6x
Wed, 23 Mar 2022	CA$869.9m	CA$87.8m	-CA$180,351,560.00	13.8x
Fri, 18 Feb 2022	CA$977.1m	CA$82.6m	-CA$178,136,821.00	14.2x
Sun, 16 Jan 2022	CA$1.1b	CA$82.9m	-CA$174,631,531.00	11x
Tue, 14 Dec 2021	CA$1.1b	CA$82.9m	-CA$171,908,718.00	12x
Thu, 11 Nov 2021	CA$1.0b	CA$78.3m	-CA$151,227,935.00	14.2x
Sat, 09 Oct 2021	CA$1.1b	CA$76.4m	-CA$145,318,143.00	14.4x
Mon, 06 Sep 2021	CA$1.2b	CA$76.4m	-CA$143,761,544.40	10.7x
Wed, 04 Aug 2021	CA$1.0b	CA$76.4m	-CA$133,419,246.40	10.3x
Sat, 08 May 2021	CA$1.2b	CA$63.7m	-CA$120,378,932.00	10.7x
Tue, 09 Feb 2021	CA$706.8m	CA$57.9m	-CA$109,052,288.00	22x
Mon, 02 Nov 2020	CA$323.4m	CA$23.7m	-CA$34,749,978.00	n/a
Thu, 06 Aug 2020	CA$286.1m	CA$31.8m	-CA$43,237,380.00	n/a
Sun, 10 May 2020	CA$269.8m	CA$21.9m	-CA$48,898,449.00	n/a
Sat, 01 Feb 2020	CA$325.8m	CA$20.6m	-CA$44,414,849.00	n/a
Tue, 05 Nov 2019	CA$224.4m	CA$19.5m	-CA$43,888,558.00	n/a
Fri, 09 Aug 2019	CA$158.3m	CA$18.1m	-CA$44,462,465.00	75.6x

Median PE Ratio

19.7x

Tue, 04 Jun 2019

Current Industry PEThere is only one profitable company in this industry, so there is insufficient data to make an industry-wide assessment of PE.

Past Earnings Growth

The earnings for companies in the Health Care Technology industry have deteriorated over the last three years.
Meanwhile revenues for these companies have grown 100% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Canadian Healthtech compare with similar industries?


CA Market	1.68%
Healthcare	0.16%
Healthtech	0.93%
Healthtech	0.93%

Industry PEThere is insufficient data on the sub-industries of this industry.

Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
TRUE Treatment.Com International	CA$0.39	28.3% +CA$5.6m	-93.5%	PB15.1x
GEMS Infinity Stone Ventures	CA$0.27	35.0% +CA$4.1m	n/a	PS20.9x
HMRK Highmark Interactive	CA$0.18	23.3% +CA$1.4m	n/a	PS7.1x
CSPN CareSpan Health	CA$0.23	15.0% +CA$925.4k	n/a	PS1x
VISN Binovi Technologies	CA$0.11	22.2% +CA$532.3k	-80.0%	PS6.8x

Company

Last Price

Valuation

TRUE Treatment.Com International

CA$0.39

28.3%
+CA$5.6m

-93.5%

PB15.1x

GEMS Infinity Stone Ventures

CA$0.27

35.0%
+CA$4.1m

n/a

PS20.9x

HMRK Highmark Interactive

CA$0.18

23.3%
+CA$1.4m

n/a

PS7.1x

CSPN CareSpan Health

CA$0.23

15.0%
+CA$925.4k

n/a

PS1x

VISN Binovi Technologies

CA$0.11

22.2%
+CA$532.3k

-80.0%

PS6.8x

Treatment.Com International Inc. announced that it has received CAD 0.34 million in funding

Treatment.Com International Inc. announced a non-brokered private placement of 400 unsecured convertible debentures at a price of CAD 850 per debenture for gross proceeds of CAD 340,000 on May 18, 2022. The debentures were issued at a discount of 15%. The debentures bear interest at a rate of 8.00% per annum, accruing on a semi-annual basis and payable, in cash or units of the company, every 6 months from the date of issue, maturing 24 months from the date of issue. Each unit will consist of one common share in the capital and one transferable share purchase warrant with each warrant being exercisable into one share at a price of CAD 0.50 per warrant share for a period of two years following the issue date. The principal amount of CAD 400,000 is convertible, at the option of the holder, into units at a conversion price equal to CAD 0.41 per unit at any time following the issue date until the earlier of the business day immediately preceding the maturity date, being May 17, 2024; and the business day immediately preceding the date fixed for redemption of the debentures by the company. The company will pay a finders fee of CAD 1,700. The debentures and the units issuable thereunder are subject to a statutory hold period of four months and one day commencing on closing.

Canadian (TSX) Healthtech Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

THNK

Think Research Corporation to Report Q1, 2022 Results on May 30, 2022

GEMS

Infinity Stone Ventures Corp. Applies Stake Six Additional Mineral Claims At Its Camaro Property

KETA

TripSitter Clinic Ltd., Annual General Meeting, Jul 19, 2022

VISN

Binovi Technologies Corp., Annual General Meeting, Jun 07, 2022

TRUE

Treatment.Com International Inc. announced that it has received CAD 0.34 million in funding

CSPN

Carespan Health, Inc. Appoints Arinder S. Mahal to Its Board of Directors

VHI

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

KSI

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

UDOC

Unidoc Health Corp. (CNSX:UDOC) entered into definitive master equipment deployment and services agreement to acquire Northern Pacific Global Investment Services Limited.

NLTA

Less than half of directors are independent

XYBN

Now 27% undervalued after recent price drop

APP

Global Cannabis Applications Corp. announced that it has received CAD 0.64 million in funding

HMRK

Full year 2021 earnings released: CA$0.17 loss per share (vs CA$0.042 loss in FY 2020)

EKG

Full year 2021 earnings released: EPS: CA$0 (vs CA$0 in FY 2020)

CDX

Full year 2021 earnings released: CA$0.17 loss per share (vs CA$2.94 loss in FY 2020)

ADK

Price target increased to CA$1.55